Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Letrozole in Preventing Breast Cancer in Postmenopausal Women Who Are at Increased Risk for Breast Cancer Due to High Breast Density

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Canadian Cancer Trials Group ( NCIC Clinical Trials Group )
ClinicalTrials.gov Identifier:
NCT00238316
First received: October 12, 2005
Last updated: May 30, 2013
Last verified: September 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2009
  Primary Completion Date: April 2006 (Final data collection date for primary outcome measure)